Merrimack Pharmaceuticals, Inc. Share Price
Equities
MACK
US5903282094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.73 USD | 0.00% | +0.07% | +9.84% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 192M 15.37B |
---|---|---|---|---|---|
Net income 2022 | -1M -80.05M | Net income 2023 | -1M -80.05M | EV / Sales 2022 | - |
Net cash position 2022 | 19.44M 1.56B | Net cash position 2023 | 18.88M 1.51B | EV / Sales 2023 | - |
P/E ratio 2022 |
-100
x | P/E ratio 2023 |
-162
x | Employees | 27 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.79% |
1 week | +0.07% | ||
Current month | -0.27% | ||
1 month | +0.07% | ||
3 months | +11.17% | ||
6 months | +20.24% | ||
Current year | +9.84% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 31/12/92 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 31/12/03 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 31/12/03 |
Director/Board Member | 45 | 18/09/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 31/12/92 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 14.73 | 0.00% | 55,162 |
25/04/24 | 14.73 | +0.14% | 82,841 |
24/04/24 | 14.71 | -0.14% | 106,490 |
23/04/24 | 14.73 | 0.00% | 79,779 |
22/04/24 | 14.73 | +0.07% | 95,000 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+9.84% | 214M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MACK Stock